Seelenberger Alexander A. 4
4 · Vincerx Pharma, Inc. · Filed Nov 17, 2022
Insider Transaction Report
Form 4
Seelenberger Alexander A.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-11-15+56,000→ 56,000 totalExercise: $0.82Exp: 2032-11-14→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]Option vests in twenty-four equal monthly installments starting from November 15, 2022.